Postsynaptic alpha adrenoceptors on vascular smooth muscle

Area of Science:

• Pharmacology
• Physiology
• Cardiovascular Research

Background:

• The canine saphenous vein (CSV) exhibits vasoconstriction mediated by alpha adrenoceptors.
• Understanding the specific roles of alpha 1 and alpha 2 adrenoceptor subtypes is crucial for elucidating vascular smooth muscle regulation.

Purpose of the Study:

• To investigate the distinct mechanisms by which alpha 1 and alpha 2 adrenoceptors mediate vasoconstriction in the canine saphenous vein.
• To differentiate the calcium signaling pathways and electrophysiological effects associated with each adrenoceptor subtype.

Main Methods:

• Incubation of isolated CSV smooth muscle strips with selective alpha-adrenoceptor agonists and antagonists.
• Measurement of contractile responses under varying external calcium concentrations (reduced or zero).
• 45Ca uptake studies and transmembrane potential measurements in smooth muscle cells.

Main Results:

• Both alpha 1 and alpha 2 adrenoceptors are present and independently mediate contractile responses in the CSV.
• Alpha 1 adrenoceptor stimulation induces contraction via extracellular calcium influx and internal calcium release.
• Alpha 2 adrenoceptor activation leads to vasoconstriction dependent solely on extracellular calcium influx, without significant depolarization (pharmacomechanical coupling).

Conclusions:

• The canine saphenous vein possesses functionally distinct alpha 1 and alpha 2 adrenoceptors mediating vasoconstriction through different calcium mobilization mechanisms.
• Alpha 1 adrenoceptors activate both electromechanical and pharmacomechanical coupling, whereas alpha 2 adrenoceptors primarily utilize pharmacomechanical coupling dependent on calcium entry.